Transaction #1826 · Form 4 · 0001193125-25-245089
AGENUS INC · Stock award · Common Stock
AGENUS INC · Transacted October 17, 2025 · Filed October 21, 2025
What does this filing report?
An SEC Form 4 filing for AGENUS INC records a stock award involving Common Stock on October 17, 2025. The reported quantity was 4,216. The filing date is October 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- AGENUS INC
- Company CIK
- 0001098972
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 4,216
- Reported price
- 3.88 · See footnotes
- Reference value
- 16,358.08
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 286,609
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2025, 4:05 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- ARMEN GARO H ↗
See Remarks · Director
CIK 0000935679
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 17, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- F2
- $3.88 is the closing price of our Common Stock on October 17, 2025, the last trading day for the payroll date for the pay period ending October 17, 2025.
- F3
- Shares are held in Dr. Armen's IRA accounts.
- F4
- Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.
Remarks
Chairman and Chief Executive Officer
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.